XML 33 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Balance Sheet Components
12 Months Ended
Dec. 31, 2022
Balance Sheet Components [Abstract]  
Balance Sheet Components 5.    Balance Sheet Components

Investments

The Company’s cash equivalents consists of $21,062,000 in money market funds as of December 31, 2021 and approximates fair value. The fair value of the Company's available-for-sale investments as of December 31, 2022 are as follows (in thousands):

December 31, 2022

Gross Unrealized

Estimated

Amortized Cost

Gains

Losses

Fair Value

Money market funds

$

55,158

$

— 

$

— 

$

55,158

U.S. treasury bills

19,772

4

— 

19,776

Commercial paper

48,875

— 

— 

48,875

Corporate bonds/notes

1,528

— 

(13)

1,515

U.S. government securities

83,432

2

(164)

83,270

Asset-backed securities

2,000

— 

(4)

1,996

Agency notes

2,876

8

— 

2,884

$

213,641

$

14

$

(181)

$

213,474

Classified as:

Cash equivalents

$

55,158

Short-term investments

158,316

$

213,474

The following table summarizes the fair value of the Company’s cash equivalents and available-for-sale investments classified by maturity as of December 31, 2022 and 2021 (in thousands):

December 31,

2022

December 31,

2021

Amounts maturing within one year

$

213,474

$

21,062

Amounts maturing after one year through two years

$

213,474

$

21,062

Available-for-sale investments held as of December 31, 2022 had a weighted average days to maturity of 163 days.

The following table presents the Company's available-for-sale investments that were in an unrealized loss position as of December 31, 2022 (in thousands):

December 31, 2022

Less than 12 months

Assets:

Fair Value

Unrealized Loss

Corporate bonds/notes

$

1,490

$

(13)

U.S. government securities

73,329

(164)

Asset-backed securities

1,994

(4)

$

76,813

$

(181)

Inventories

Components of inventories were as follows (in thousands):

2022

2021

Raw materials

$

4,913

$

2,447

Finished products

14,380

15,404

$

19,293

$

17,851

As of December 31, 2022 and 2021, there were no work-in-process inventories.

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

December 31,

2022

2021

Furniture and fixtures

$

1,822

$

1,005

Equipment

5,046

2,945

Software

296

284

Leasehold improvements

7,246

2,050

14,410

6,284

Less: Accumulated depreciation

(5,355)

(3,330)

Add: Construction-in-progress

317

4,743

$

9,372

$

7,697

Depreciation and amortization expense was $2,127,000, $1,032,000 and $789,000 for the years ended December 31, 2022, 2021 and 2020, respectively.

Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

December 31,

2022

2021

Accrued payroll and related expenses

$

15,216

$

13,898

Operating lease liability

1,844

1,294

Accrued royalty expense

973

687

Accrued professional services

781

2,039

Accrued travel expenses

775

590

Provision for sales returns

540

359

Accrued interest payable

519

14

Deferred revenue

253

157

Accrued clinical expenses

249

99

Accrued other expenses

815

665

$

21,965

$

19,802